LIFECORE BIOMEDICAL, INC. Impairment of Intangible Assets (Excluding Goodwill)
LIFECORE BIOMEDICAL, INC. (LFCR) reported Impairment of Intangible Assets (Excluding Goodwill) of $0 for the 3-month period ending 2023-02-26, per its 10-Q filed 2023-06-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2023-06-02
- LIFECORE BIOMEDICAL, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2023-02-26 was $0.00.
- LIFECORE BIOMEDICAL, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2022-11-27 was $1.30M.
- LIFECORE BIOMEDICAL, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2022-02-27 was $0.00.
- LIFECORE BIOMEDICAL, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2021-11-28 was $0.00.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month |
|---|---|---|---|
| 2023-02-26 | $0.00 10-Q · filed 2023-06-02 | $1.30M derived: sum of 2 quarters · filed 2023-06-02 | $300.00K 10-Q · filed 2023-06-02 |
| 2022-11-27 | $1.30M 10-Q · filed 2023-03-16 | $1.30M 10-Q · filed 2023-03-16 | |
| 2022-02-27 | $0.00 10-Q · filed 2023-06-02 | $0.00 derived: sum of 2 quarters · filed 2023-06-02 | $0.00 10-Q · filed 2023-06-02 |
| 2021-11-28 | $0.00 10-Q · filed 2023-03-16 | $0.00 10-Q · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |